DYN
Price
$14.13
Change
-$0.64 (-4.33%)
Updated
Jan 17 closing price
Capitalization
1.44B
39 days until earnings call
WINT
Price
$0.22
Change
-$0.01 (-4.35%)
Updated
Jan 17 closing price
Capitalization
1.97M
Ad is loading...

DYN vs WINT

Header iconDYN vs WINT Comparison
Open Charts DYN vs WINTBanner chart's image
Dyne Therapeutics
Price$14.13
Change-$0.64 (-4.33%)
Volume$2.48M
Capitalization1.44B
Windtree Therapeutics
Price$0.22
Change-$0.01 (-4.35%)
Volume$1.55M
Capitalization1.97M
DYN vs WINT Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. WINT commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and WINT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (DYN: $14.13 vs. WINT: $0.22)
Brand notoriety: DYN and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 181% vs. WINT: 64%
Market capitalization -- DYN: $1.44B vs. WINT: $1.97M
DYN [@Biotechnology] is valued at $1.44B. WINT’s [@Biotechnology] market capitalization is $1.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, WINT is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while WINT’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 3 bearish.
  • WINT’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, WINT is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а -10.96% price change this week, while WINT (@Biotechnology) price change was -14.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

DYN is expected to report earnings on May 01, 2025.

WINT is expected to report earnings on May 17, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.44B) has a higher market cap than WINT($1.97M). WINT YTD gains are higher at: -37.275 vs. DYN (-40.025). WINT has higher annual earnings (EBITDA): -9.36M vs. DYN (-312.84M). DYN has more cash in the bank: 724M vs. WINT (2.3M). WINT has less debt than DYN: WINT (2.01M) vs DYN (24.9M). DYN (0) and WINT (0) have equivalent revenues.
DYNWINTDYN / WINT
Capitalization1.44B1.97M72,995%
EBITDA-312.84M-9.36M3,342%
Gain YTD-40.025-37.275107%
P/E RatioN/A0.83-
Revenue00-
Total Cash724M2.3M31,478%
Total Debt24.9M2.01M1,237%
FUNDAMENTALS RATINGS
WINT: Fundamental Ratings
WINT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNWINT
RSI
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 12 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
82%
Momentum
ODDS (%)
Bearish Trend 12 days ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 12 days ago
81%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 25 days ago
87%
Bullish Trend 20 days ago
74%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 12 days ago
85%
Aroon
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 12 days ago
90%
View a ticker or compare two or three
Ad is loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGFFX40.820.31
+0.77%
Edgewood Growth Retail
UGTAX27.940.17
+0.61%
Victory Growth and Tax Strategy A
FBPEX26.450.12
+0.46%
Cantor Fitzgerald Equity Div Plus Inst
NAMAX14.200.06
+0.42%
Columbia Select Mid Cap Value Instl
WEMCX6.920.01
+0.14%
Allspring Emerging Growth C

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-4.33%
RNA - DYN
48%
Loosely correlated
+2.23%
AXON - DYN
43%
Loosely correlated
+1.37%
IGMS - DYN
42%
Loosely correlated
-3.28%
PCVX - DYN
41%
Loosely correlated
-2.88%
ROIV - DYN
40%
Loosely correlated
+2.39%
More

WINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been loosely correlated with MLEC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WINT jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
-3.44%
MLEC - WINT
49%
Loosely correlated
-1.29%
DVHGF - WINT
37%
Loosely correlated
N/A
INMB - WINT
31%
Poorly correlated
-4.02%
DYN - WINT
28%
Poorly correlated
-4.33%
ESLA - WINT
28%
Poorly correlated
+0.68%
More